Cargando…

P87 - A national multicenter registration of treatment with omalizumab in Danish asthmatic children

Detalles Bibliográficos
Autores principales:	Spangenberg, Katrine B, Jørgensen, Inger Merete, Halken, Susanne, Agertoft, Lone, Buchwald, Frederik, Rubak, Sune, Friberg, Margrethe, Fomsgaard Kjær, Henrik, Houmann, Thomas Petersen, Kongstad, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082061/ http://dx.doi.org/10.1186/2045-7022-4-S1-P142

Ejemplares similares

Microfibrillar‐associated protein 4 in serum is associated with asthma in Danish adolescents and young adults
por: Hoffmann‐Petersen, Benjamin, et al.
Publicado: (2019)

Validity of asthma diagnoses and patterns of anti‐asthmatic drug use in a cohort of 2053 Danish children
por: Rubak, Sune, et al.
Publicado: (2018)

Efficacy of Omalizumab Therapy in an Asthmatic with Low IgE
por: R, Divya, et al.
Publicado: (2020)

Association of serum surfactant protein D and SFTPD gene variants with asthma in Danish children, adolescents, and young adults
por: Hoffmann‐Petersen, Benjamin, et al.
Publicado: (2021)

The use of direct oral challenge to confirm allergies to penicillin class antibiotics in Danish children
por: Krusenstjerna-Hafstrøm, Thomas, et al.
Publicado: (2020)

Effectiveness of omalizumab in an asthmatic patient with severe airway and blood eosinophilia
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2015)

Metabolomic applied to omalizumab effect in severe asthmatics – a preliminary result
por: Loureiro, Cláudia Chaves, et al.
Publicado: (2013)

Effective omalizumab treatment influenced eosinophil function in severe allergic asthmatics
por: Yan, Huacheng, et al.
Publicado: (2023)

Influence of the diagnosis chronic rhinosinusitis on asthma response to omalizumab in severe, uncontrolled asthmatics
por: Sintobin, Ina, et al.
Publicado: (2015)

The Danish National Database for Asthma
por: Backer, Vibeke, et al.
Publicado: (2016)

Exercise performance after salbutamol inhalation in non-asthmatic, non-athlete individuals: a randomised, controlled, cross-over trial
por: Eckerström, Filip, et al.
Publicado: (2018)

Follow-up of asthma control and quality of life after discontinuation of omalizumab in severe asthmatic patients
por: Nayci, Sibel, et al.
Publicado: (2015)

Incompleteness of oral cancer registration in south-east England, 1971-87.
por: Warnakulasuriya, K. A., et al.
Publicado: (1994)

Cancer in electrical workers: an analysis of cancer registrations in England, 1981-87.
por: Fear, N. T., et al.
Publicado: (1996)

Real-World Clinical Outcomes in Asthmatic Patients Switched from Omalizumab to Anti-Interleukin-5 Therapy
por: O’Reilly, Emily, et al.
Publicado: (2022)

Omalizumab in Children
por: Licari, Amelia, et al.
Publicado: (2014)

Quality of life in asthmatic children and their caregivers after two-year treatment with omalizumab, a real-life study
por: Sztafińska, Anna, et al.
Publicado: (2017)

Early childhood risk factors for rhinoconjunctivitis in adolescence: a prospective birth cohort study
por: Christiansen, Elisabeth Soegaard, et al.
Publicado: (2017)

Physical Activity as a New Tool to Evaluate the Response to Omalizumab and Mepolizumab in Severe Asthmatic Patients: A Pilot Study
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2020)

Cohort profile: the vitamin A and D and nitric oxide (AD-ON) observational cohort on lung development and symptoms in premature and mature children in North Zealand, Denmark
por: Goth, Fanny Edit Maria, et al.
Publicado: (2022)

Pier-87
por: Mr. SAETERSKOG, Petter, et al.
Publicado: (2015)

The Danish National Database for Asthma: establishing clinical quality indicators
por: Hansen, Susanne, et al.
Publicado: (2016)

Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic asthma
por: Jung, Jae-Woo, et al.
Publicado: (2021)

Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic asthma
por: Jung, Jae-Woo, et al.
Publicado: (2021)

Hydatidiform mole: validity of the registration in the Danish National Patient Registry, the Danish Cancer Registry, and the Danish Pathology Registry 1999–2009
por: Lund, Helle, et al.
Publicado: (2018)

Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
por: Pennington, Luke F., et al.
Publicado: (2016)

Collision-constrained deformable image registration framework for discontinuity management
por: Alscher, Thomas, et al.
Publicado: (2023)

Reversible lung fibrosis in a 6-year-old girl after long term nitrofurantoin treatment
por: Mikkelsen, Lise Fischer, et al.
Publicado: (2020)

Omalizumab—A Review
por: Godse, Kiran, et al.
Publicado: (2015)

Threshold response of stomatal closing ability to leaf abscisic acid concentration during growth
por: Giday, Habtamu, et al.
Publicado: (2014)

EXM-87-09: 03/09/87
por: Martucci, P, et al.
Publicado: (1987)

EXM-87-17: 19/11/87
por: Martucci, P, et al.
Publicado: (1987)

EXM-87-20: 17/12/87
por: Martucci, P, et al.
Publicado: (1988)

EXM-87-14: 22/10/87
por: Martucci, P, et al.
Publicado: (1987)

EXM-87-18: 26/11/87
por: Martucci, P
Publicado: (1987)

Omalizumab in the management of patients with allergic (IgE-mediated) asthma
por: Sandström, Thomas
Publicado: (2009)

Testing the feasibility of the Dignity Therapy interview: adaptation for the Danish culture
por: Houmann, Lise J, et al.
Publicado: (2010)

Adherence to adrenaline autoinjector prescriptions in patients with anaphylaxis
por: Parke, Louise, et al.
Publicado: (2019)

Severe asthma and the omalizumab option
por: Miller, Christopher WT, et al.
Publicado: (2008)

Omalizumab treatment in brittle asthma
por: Skiepko, Roman, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4ha60ogura3r2gnllt74dgt6lj